SRPT Stock Balance Sheets

Sarepta Therapeutics Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Long-Term Debt

Inventory

Sarepta Therapeutics Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2002-12-31	2001-12-31	2001-06-30	2001-03-31

assets
current assets:
cash and cash equivalents	510,598,000	240,867,000	1,103,010,000	197,855,000	383,622,000	427,290,000	428,430,000	541,932,000	851,929,000	871,668,000	966,777,000	1,038,624,000	868,565,000	1,233,877,000	2,115,869,000	1,599,113,000	1,697,275,000	1,481,836,000	1,502,648,000	1,474,637,000	1,639,959,000	1,764,212,000	835,080,000	724,829,000	808,591,000	732,190,000	370,829,000	209,702,000	410,375,000	557,234,000	599,691,000	617,630,000	168,348,000	274,723,000	122,420,000	395,140,000	111,819,000	38,001,000	80,304,000	55,819,000	69,538,000	74,436,000	73,551,000	52,299,000	102,754,000	49,101,000	256,965,000	273,644,000	156,185,000	167,919,000	187,661,000	37,987,000	24,491,000	30,573,000	39,904,000	46,356,000	54,188,000	23,283,000	33,589,000	35,967,000	36,742,000	41,438,000		50,268,000	20,037,000	24,723,000	11,192,238	14,081,213	18,509,474	19,960,809	24,802,562	3,861,272	9,263,512	14,964,915	25,578,248	31,764,383	36,867,301	34,597,734	27,556,780	27,346,075	34,356,842	16,654,829	12,341,849	11,044,909	10,384,963	11,069,451	28,132,365	22,001,736
short-term investments	289,541,000	281,895,000	251,782,000	1,000,534,000	1,076,852,000	963,453,000	1,247,820,000	1,191,610,000	1,008,786,000	1,010,429,000	1,022,597,000	1,033,860,000	1,059,454,000	779,548,000			30,000,000	255,997,000	435,923,000	341,467,000	421,349,000	406,940,000	289,668,000	324,063,000	294,478,000	612,018,000	803,083,000	583,158,000	538,769,000	491,757,000	479,369,000		132,598,000	115,590,000	195,425,000		11,396,000	91,155,000	112,187,000	44,090,000	87,349,000	91,787,000	136,793,000	183,718,000	176,785,000	176,091,000
accounts receivable	527,295,000	659,371,000	601,988,000	434,524,000	359,997,000	378,806,000	400,327,000	318,855,000	236,808,000	223,836,000	214,628,000	201,509,000	203,854,000	178,194,000	152,990,000	149,787,000	127,520,000	118,203,000	101,340,000	121,827,000	104,028,000	106,875,000	90,879,000	68,032,000	56,981,000	50,510,000	49,044,000	48,601,000	42,985,000	39,848,000	29,468,000	24,751,000	17,791,000	12,278,000	5,228,000	3,986,000	3,982,000	3,990,000	3,977,000	2,733,000	2,416,000	2,416,000	2,416,000	3,362,000	5,226,000	7,849,000	3,530,000	6,721,000	3,788,000	5,652,000	4,713,000	2,474,000	7,180,000	5,135,000	3,633,000	4,267,000	10,892,000	13,576,000	3,224,000	5,241,000	2,153,000	1,648,000		5,671,000	3,360,000	3,126,000	4,971,495	4,076,586	2,666,419	4,053,301	2,869,760	1,751,367	1,119,780	551,783	61,342	44,389	840,153	1,236,446
inventory	994,036,000	941,432,000	749,960,000	565,924,000	485,795,000	373,530,000	322,859,000	244,011,000	226,876,000	202,675,000	203,968,000	221,192,000	208,095,000	198,997,000	186,212,000	288,469,000	268,756,000	240,333,000	231,961,000	220,118,000	179,650,000	173,168,000	171,379,000	166,360,000	156,569,000	140,467,000	125,445,000	115,816,000	104,126,000	99,375,000	83,605,000	64,693,000	41,754,000	30,445,000	12,813,000	2,921,000
manufacturing-related deposits and prepaids	207,921,000	203,490,000	276,262,000	321,055,000	302,627,000	238,821,000
other current assets	127,594,000	105,478,000	90,461,000	165,477,000	74,743,000	82,965,000	179,895,000	154,441,000	148,215,000	179,769,000	149,891,000	130,744,000	129,332,000	140,331,000	149,028,000	147,941,000	141,666,000	174,981,000	213,324,000	164,624,000	114,435,000	96,153,000	81,907,000	79,015,000	110,799,000	136,238,000	77,782,000	54,800,000	42,989,000	31,203,000	36,511,000	27,033,000	28,565,000	22,742,000	26,895,000	22,002,000	15,302,000	16,885,000	17,380,000	19,466,000	23,091,000	24,410,000	35,036,000	26,436,000	15,906,000	9,079,000	3,061,000	2,807,000	5,683,000	3,023,000	1,534,000	1,698,000	1,561,000	1,924,000	1,647,000	1,322,000	943,000	1,636,000	1,025,000	1,106,000	1,037,000	891,000		839,000	764,000	645,000	598,562	1,222,654	1,093,968	1,075,033	767,278	952,987	775,179	709,486	802,973	583,500	480,547	365,866	542,528	244,696	283,117	683,075	698,789	474,316	595,093	198,923	1,131,114	858,192
total current assets	2,656,985,000	2,432,533,000	3,073,463,000	2,685,369,000	2,683,636,000	2,464,865,000	2,579,331,000	2,450,849,000	2,472,614,000	2,488,377,000	2,557,861,000	2,625,929,000	2,469,300,000	2,530,947,000	2,604,099,000	2,185,310,000	2,265,217,000	2,271,350,000	2,485,196,000	2,322,673,000	2,459,421,000	2,547,348,000	1,468,913,000	1,362,299,000	1,427,418,000	1,671,423,000	1,426,183,000	1,012,077,000	1,139,244,000	1,219,417,000	1,228,644,000	735,608,000	390,585,000	457,307,000	373,476,000	434,744,000	153,194,000	160,726,000	224,543,000	122,108,000	182,394,000	193,049,000	247,796,000	269,815,000	304,671,000	249,370,000	270,806,000	290,422,000	172,906,000	176,594,000	193,908,000	42,159,000	33,232,000	37,632,000	45,184,000	51,945,000	66,023,000	38,495,000	37,838,000	42,314,000	39,932,000	44,149,000		56,947,000	24,329,000	28,779,000	17,044,357	19,659,981	22,546,479	25,363,352	28,711,451	16,754,113	21,215,260	28,307,380	39,289,335	45,101,376	50,767,209	48,653,394	31,499,939	32,430,934	37,474,609	20,198,391	23,803,614	29,648,455	20,401,988	27,511,076	35,859,956	27,478,134
property and equipment	371,857,000	360,587,000	340,336,000	305,788,000	276,200,000	249,302,000	227,154,000	212,367,000	188,874,000	182,862,000	180,037,000	181,005,000	183,292,000	187,248,000	191,156,000	199,249,000	203,330,000	203,107,000	190,430,000	171,715,000	153,340,000	137,325,000	129,620,000																				38,501,000
right of use assets	143,041,000	147,063,000	148,310,000	140,898,000	124,001,000	126,269,000	129,952,000	133,454,000	134,728,000	62,016,000	64,954,000	43,034,000	46,999,000	45,982,000	45,531,000	72,663,000	72,868,000	65,068,000	91,761,000	71,085,000	74,197,000	63,097,000	37,933,000
non-current inventory	194,668,000	181,158,000	187,986,000	202,550,000	204,691,000	207,542,000	191,368,000	176,112,000	166,635,000	164,144,000
strategic investments	195,522,000	154,370,000
non-current investments	34,604,000	109,125,000	133,163,000	181,770,000
other non-current assets	83,137,000	80,551,000	79,915,000	83,559,000	135,729,000	176,407,000	136,771,000	136,925,000	163,039,000	162,387,000	317,936,000	293,124,000	284,200,000	278,649,000	292,949,000	190,792,000	203,553,000	211,584,000	203,703,000	201,847,000	182,980,000	186,805,000	173,859,000									10,988,000	11,582,000	7,346,000		8,051,000	6,942,000	8,145,000
total assets	3,679,814,000	3,465,387,000	3,963,173,000	3,599,934,000	3,424,257,000	3,224,385,000	3,264,576,000	3,109,707,000	3,125,890,000	3,059,786,000	3,128,366,000	3,156,149,000	2,996,853,000	3,056,154,000	3,147,974,000	2,662,218,000	2,759,073,000	2,765,233,000	2,984,718,000	2,780,664,000	2,883,043,000	2,947,388,000	1,822,822,000	1,702,470,000	1,747,753,000	1,963,895,000	1,642,075,000	1,182,906,000	1,247,160,000	1,300,283,000	1,307,964,000	800,281,000	450,139,000	511,533,000	424,104,000	487,310,000	204,068,000	213,364,000	273,782,000	184,751,000	231,710,000	242,708,000	295,033,000	319,058,000	337,309,000	275,389,000	291,569,000	304,479,000	183,633,000	193,340,000	204,993,000	53,082,000	42,101,000	46,647,000	54,368,000	61,083,000	74,933,000	47,031,000	45,976,000	50,860,000	48,667,000	52,825,000		65,123,000	32,617,000	37,017,000	25,535,828	29,514,946	32,578,172	35,479,866	38,637,930	26,864,835	31,208,514	35,307,047	46,542,091	52,384,016	58,119,048	56,407,982	39,516,477	40,542,949	45,698,213	28,518,631	32,373,194	38,142,082	28,603,757	33,815,113	39,372,503	30,456,128
liabilities and stockholders’ equity
current liabilities:
accounts payable	136,702,000	156,105,000	214,442,000	118,774,000	107,417,000	91,536,000	164,918,000	87,948,000	109,796,000	106,710,000	95,875,000	118,461,000	56,207,000	54,007,000	76,741,000	44,163,000	76,681,000	76,651,000	111,090,000	74,528,000	91,660,000	26,595,000	68,094,000	81,946,000	44,045,000	26,499,000	33,829,000	20,408,000	17,382,000	17,379,000	8,467,000	5,317,000	10,921,000	27,446,000	29,690,000	20,684,000	17,133,000	18,673,000	20,234,000	7,431,000	14,095,000	9,318,000	12,408,000	967,000	1,309,000	7,721,000	17,634,000	8,129,000	6,727,000	7,073,000	7,532,000	4,334,000	8,813,000	8,195,000	9,396,000	7,899,000	10,975,000	6,484,000	1,311,000	4,945,000	2,369,000	1,761,000		4,303,000	1,506,000	1,279,000	2,014,130	3,258,153	2,325,242	3,367,551	3,026,072	5,274,320	2,348,603	1,889,929	1,155,961	1,288,154	1,250,512	1,861,604	1,641,261	1,256,438	1,574,051	1,456,196	737,067	1,608,139	4,540,745	2,772,434	1,245,126	1,217,702
accrued expenses	377,399,000	391,650,000	373,513,000	344,830,000	350,404,000	283,317,000	314,997,000	322,350,000	326,877,000	345,554,000	418,996,000	368,998,000	383,699,000	293,908,000	271,697,000	221,009,000	240,141,000	180,636,000	193,553,000	199,063,000	159,088,000	176,298,000	185,527,000	121,663,000	107,328,000	100,120,000	134,095,000	88,687,000	72,477,000	65,648,000	68,982,000	55,752,000	39,179,000	31,157,000	31,016,000	29,539,000	35,064,000	24,277,000	29,053,000	19,761,000	15,184,000	15,039,000	17,366,000	14,824,000	13,839,000	16,340,000
deferred revenue, current portion	395,431,000	44,859,000	130,256,000	127,001,000	122,036,000	112,000,000	50,416,000	22,494,000	44,989,000	67,239,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,244,000	89,311,000	91,073,000
other current liabilities	10,416,000	12,974,000	13,473,000	17,289,000	17,128,000	16,270,000		17,951,000	16,992,000	17,381,000	15,489,000	26,213,000	16,416,000	17,803,000	15,051,000	19,027,000	18,956,000	18,205,000	22,139,000	15,553,000	14,837,000	12,463,000	11,146,000	8,944,000	7,413,000	6,762,000	2,463,000	1,995,000	2,011,000	4,723,000	1,392,000	1,366,000	1,340,000	1,377,000	1,305,000	1,300,000	1,324,000	1,303,000	1,275,000	1,283,000	1,372,000						888,000	15,000	15,000
total current liabilities	919,948,000	605,588,000	731,684,000	699,489,000	688,490,000	608,709,000	653,659,000	450,743,000	498,654,000	536,884,000	619,604,000	602,916,000	545,566,000	454,962,000	452,733,000	373,443,000	425,022,000	364,736,000	416,026,000	378,388,000	354,896,000	306,429,000	264,767,000	215,856,000	162,089,000	137,366,000	173,690,000	114,393,000	104,687,000	91,196,000	88,332,000	70,470,000	65,960,000	74,629,000	75,422,000	64,933,000	66,930,000	55,160,000	62,294,000	37,667,000	38,962,000	33,906,000	36,867,000	22,726,000	29,404,000	37,758,000	35,966,000	51,101,000	92,433,000	103,659,000	78,886,000	55,200,000	17,131,000	29,923,000	20,601,000	26,531,000	36,938,000	43,220,000	45,857,000	43,765,000	37,268,000	26,341,000		43,059,000	26,288,000	11,616,000	7,287,576	10,666,058	8,826,906	12,141,612	9,752,329	9,550,330	4,886,894	4,346,755	2,182,879	2,264,821	2,209,804	2,747,973	2,522,589	1,926,660	2,277,914	2,249,598	1,349,437	2,166,913	5,122,134	3,281,066	1,614,158	1,617,801
long-term debt	1,139,458,000	1,138,289,000	1,137,124,000	1,135,965,000	1,134,810,000	1,133,660,000	1,132,515,000	1,236,755,000	1,235,517,000	1,234,284,000	1,544,292,000	1,542,770,000	1,100,873,000	1,098,847,000	1,096,876,000	1,094,912,000	1,092,985,000	1,091,110,000	992,493,000	700,470,000	694,156,000	687,953,000	681,900,000	436,421,000	431,040,000	425,752,000	420,554,000	415,446,000	429,925,000	427,365,000	424,876,000	26,550,000		2,343,000	6,042,000	8,491,000	10,111,000	13,373,000	14,969,000	17,397,000	20,652,000	1,450,000	1,476,000	1,501,000	1,525,000	1,551,000	1,576,000	1,599,000		1,645,000
lease liabilities, net of current portion	214,419,000	205,460,000	192,473,000	170,009,000	143,601,000	140,102,000	140,965,000	134,752,000	129,170,000	53,931,000	57,578,000	35,229,000	39,368,000	38,620,000	41,512,000	63,428,000	65,285,000	60,675,000	80,367,000
deferred revenue, net of current portion		325,000,000	325,000,000	325,000,000	325,000,000	325,000,000	437,000,000	485,000,000	485,000,000	485,000,000	485,000,000	507,494,000	529,989,000	552,239,000	574,244,000	596,738,000	619,233,000	641,483,000	663,488,000	685,982,000	708,476,000	732,667,000
contingent consideration	47,400,000	47,400,000	47,400,000	47,400,000	48,200,000	48,200,000	38,100,000	38,100,000	36,100,000	36,900,000	36,900,000	36,900,000	43,600,000	43,600,000	43,600,000	43,600,000	50,800,000	50,800,000	50,800,000	50,500,000
other non-current liabilities	1,204,000	927,000	1,750,000	1,000,000	7,087,000	7,522,000	3,000,000		38,000	38,000	42,000		11,000,000	11,000,000	11,000,000	20,569,000	20,640,000	20,984,000	19,785,000	5,048,000	10,248,000	10,248,000	10,248,000
total liabilities	2,322,429,000	2,322,664,000	2,435,431,000	2,378,863,000	2,347,188,000	2,263,193,000	2,405,239,000	2,345,350,000	2,384,479,000	2,347,037,000	2,743,416,000	2,725,309,000	2,270,396,000	2,199,268,000	2,219,965,000	2,192,690,000	2,273,965,000	2,229,788,000	2,222,959,000	1,888,617,000	1,840,177,000	1,802,560,000	1,004,635,000	707,266,000	648,586,000	615,331,000	609,799,000	543,058,000	548,113,000	523,523,000	518,747,000	103,125,000	72,367,000	82,391,000	87,413,000	78,686,000	82,608,000	74,402,000	83,435,000	61,515,000	66,334,000	41,949,000	47,380,000	32,854,000	37,388,000	46,427,000	44,377,000	57,495,000	94,812,000	106,059,000
commitments and contingencies																																																					0
stockholders’ equity:
preferred stock, 0.0001 par value, 3,333,333 shares authorized; none issued and outstanding
common stock	10,000	10,000	10,000	10,000	10,000	9,000	9,000	9,000	9,000	9,000	9,000	9,000	9,000	9,000	9,000	8,000	8,000	8,000	8,000	8,000	8,000	8,000	8,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	6,000	6,000	6,000	5,000	5,000	5,000	5,000	5,000	5,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	3,000	3,000	3,000	2,000	2,000	13,000	13,000	13,000	14,000	11,000	11,000	11,000	11,000	11,000		11,000	9,000	9,000	7,110	7,116	7,109	7,043	6,445	5,373	5,365	5,328	5,297	5,296	5,293	5,118	4,418	4,418	4,415	3,614	3,612	3,612	2,656	2,322	2,307	2,153
treasury stock	-25,263,000
additional paid-in capital	5,844,279,000	5,801,161,000	5,738,924,000	5,588,839,000	5,481,723,000	5,371,968,000	5,304,623,000	5,256,854,000	5,193,388,000	5,140,150,000	4,296,841,000	4,235,028,000	4,272,187,000	4,168,956,000	4,134,768,000	3,554,307,000	3,521,721,000	3,490,658,000	3,609,877,000	3,550,857,000	3,505,165,000	3,455,689,000	3,112,130,000	3,053,420,000	3,031,050,000	3,004,107,000	2,611,294,000	2,077,864,000	2,061,039,000	2,029,767,000	2,006,598,000	1,890,172,000	1,523,080,000	1,511,422,000	1,503,126,000	1,486,487,000	1,142,580,000	1,097,787,000	1,089,508,000	957,607,000	947,826,000	941,356,000	926,769,000	920,864,000	905,335,000	800,526,000	790,424,000	781,396,000	581,204,000	560,613,000	554,927,000	364,616,000	342,128,000	341,677,000	340,968,000	340,293,000	339,669,000	306,722,000	304,818,000	304,154,000	301,139,000	299,515,000		298,487,000	274,684,000	274,118,000	266,034,912	265,501,292	264,358,554	262,151,126	252,732,858	237,450,696	246,190,431	244,382,818	239,726,657	238,708,122	237,598,487	226,290,167	205,086,142	205,016,072	204,887,443	182,370,440	182,297,550	182,271,542	139,327,069	116,711,776	116,075,119	105,587,511
accumulated other comprehensive loss, net of tax	-51,000							-638,000	-1,055,000	-419,000	-1,664,000	-3,205,000	-2,485,000	-306,000
accumulated deficit	-4,461,590,000	-4,658,482,000	-4,210,974,000	-4,370,023,000	-4,403,634,000	-4,410,094,000	-4,446,213,000	-4,491,868,000	-4,450,931,000	-4,426,991,000	-3,910,236,000	-3,800,992,000	-3,543,254,000	-3,311,773,000	-3,206,748,000	-3,084,767,000	-3,036,623,000	-2,955,218,000	-2,848,129,000	-2,658,812,000	-2,462,313,000	-2,311,493,000	-2,294,001,000	-2,058,298,000	-1,931,972,000	-1,655,569,000	-1,578,926,000	-1,438,031,000	-1,361,638,000	-1,252,371,000	-1,217,008,000	-1,193,010,000	-1,145,276,000	-1,082,230,000	-1,166,320,000	-1,077,868,000	-1,021,126,000	-958,825,000	-899,055,000	-834,374,000	-782,435,000	-740,584,000	-679,025,000	-634,609,000	-605,383,000
total stockholders’ equity	1,357,385,000	1,142,723,000	1,527,742,000	1,221,071,000	1,077,069,000	961,192,000	859,337,000	764,357,000	741,411,000	712,749,000	384,950,000	430,840,000	726,457,000	856,886,000	928,009,000	469,528,000	485,108,000	535,445,000	761,759,000	892,047,000	1,042,866,000	1,144,828,000	818,187,000	995,204,000	1,099,167,000	1,348,564,000	1,032,276,000	639,848,000	699,047,000	776,760,000	789,217,000	697,156,000	377,772,000	429,142,000	336,691,000	408,624,000	121,460,000	138,962,000	190,347,000	123,236,000	165,376,000	200,759,000	247,653,000	286,204,000	299,921,000	228,962,000	247,192,000	246,984,000	88,821,000
total liabilities and stockholders’ equity	3,679,814,000	3,465,387,000	3,963,173,000	3,599,934,000	3,424,257,000	3,224,385,000	3,264,576,000	3,109,707,000	3,125,890,000	3,059,786,000	3,128,366,000	3,156,149,000	2,996,853,000	3,056,154,000	3,147,974,000	2,662,218,000	2,759,073,000	2,765,233,000	2,984,718,000	2,780,664,000	2,883,043,000	2,947,388,000	1,822,822,000	1,702,470,000	1,747,753,000	1,963,895,000	1,642,075,000	1,182,906,000	1,247,160,000	1,300,283,000	1,307,964,000	800,281,000	450,139,000	511,533,000	424,104,000	487,310,000	204,068,000	213,364,000	273,782,000	184,751,000	231,710,000	242,708,000	295,033,000	319,058,000	337,309,000	275,389,000	291,569,000	304,479,000	183,633,000
accumulated other comprehensive income, net of tax		34,000	-218,000	2,245,000	-1,030,000	-691,000	918,000								-20,000	-20,000	2,000	-3,000	3,000	-6,000	6,000	624,000	50,000
current portion of long-term debt				91,595,000	91,505,000	105,586,000	105,483,000																						9,514,000	3,446,000	6,175,000	4,732,000	11,217,000	11,346,000	10,108,000	10,107,000	10,106,000	7,604,000	5,936,000	3,435,000	100,000	99,000	98,000	97,000	96,000	94,000	92,000	91,000
current portion of lease liabilities							17,845,000
intangible assets											7,578,000	13,057,000	13,062,000	13,328,000	14,239,000	14,204,000	14,105,000	14,124,000	13,628,000	13,344,000	13,105,000	12,813,000	12,497,000
preferred stock, .0001 par value, 3,333,333 shares authorized; none issued and outstanding																																																				0	0
lease liabilities																				68,229,000	72,401,000	65,263,000	47,720,000	49,741,000	50,209,000	52,165,000
property and equipment, net of accumulated depreciation of 44,701 and 28,149 as of september 30, 2019, and december 31, 2018, respectively																								119,532,000
intangible assets, net of accumulated amortization of 5,091 and 3,852 as of september 30, 2019, and december 31, 2018, respectively																								11,975,000
right of use asset																								39,493,000	39,449,000
other assets																								169,171,000	151,860,000	133,313,000		78,664,000	35,435,000	12,466,000					3,967,000				4,470,000	7,670,000	5,313,000	5,275,000	2,063,000	5,729,000	6,441,000	25,000	25,000	25,000	1,625,000	1,525,000	2,775,000	2,425,000	231,000	206,000	155,000	139,000	123,000	386,000	123,000	111,000	111,000	111,000		121,000	78,000	35,000	34,709	34,709	34,709	34,709	34,709	34,709	34,709	284,709	34,709	34,709	34,709	37,609	37,609	37,609	37,609	37,609	34,709	34,709	29,847	29,847	29,847	29,847
deferred revenue																								3,303,000	3,303,000	3,985,000	3,303,000	3,303,000	3,303,000		3,316,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,303,000	3,363,000	3,318,000	3,362,000	3,303,000	3,303,000	3,299,000	3,963,000	4,499,000	3,884,000	3,304,000	3,304,000	3,304,000	3,304,000	3,304,000	3,304,000	3,304,000	3,304,000	3,304,000	3,335,000	3,366,000	3,409,000		2,096,000	2,128,000	2,159,000	2,190,000	2,243,750	2,275,000	1,596,250	737,500
deferred rent and other																								5,248,000	5,248,000	48,000	15,555,000	13,219,000	13,501,000	4,962,000	5,539,000	6,105,000	6,407,000	5,419,000	5,949,000	5,262,000	5,567,000	5,869,000	6,172,000	6,451,000	6,720,000
accumulated other comprehensive income																								75,000	82,000	19,000		8,000									1,000																																					16,377	19,327	17,200	14,858	12,968							729,956	1,038,956		-13,278,794
property and equipment, net of accumulated depreciation of 38,398 and 28,149 as of june 30, 2019, and december 31, 2018, respectively																									117,201,000
intangible assets, net of accumulated amortization of 4,685 and 3,852 as of june 30, 2019, and december 31, 2018, respectively																									11,825,000
property and equipment, net of accumulated depreciation of 32,612 and 28,149 as of march 31, 2019, and december 31, 2018, respectively																										106,280,000
intangible assets, net of accumulated amortization of 4,276 and 3,852 as of march 31, 2019, and december 31, 2018, respectively																										11,781,000
right of use asset, net of accumulated amortization of 1,491 and nil as of march 31, 2019 and december 31, 2018, respectively																										41,098,000
property and equipment, net of accumulated depreciation of 28,149 and 18,022 as of december 31, 2018 and 2017, respectively																											97,024,000
intangible assets, net of accumulated amortization of 3,852 and 4,145 as of december 31, 2018 and 2017, respectively																											11,574,000
investments and other assets																											107,294,000				21,809,000
accumulated other comprehensive loss																											-99,000		-361,000	-643,000	-379,000	-12,000	-38,000	-55,000	-120,000			-5,000	-111,000	-1,000		-17,000	-95,000	-55,000	-35,000	-59,000
property and equipment, net of accumulated depreciation of 25,224 and 18,022 as of september 30, 2018, and december 31, 2017, respectively																												76,841,000
intangible assets, net of accumulated amortization of 5,532 and 4,145 as of september 30, 2018, and december 31, 2017, respectively																												15,324,000
property and equipment, net of accumulated depreciation of 22,124 and 18,022 as of june 30, 2018 and december 31, 2017, respectively																													57,624,000
intangible assets, net of accumulated amortization of 5,100 and 4,145 as of june 30, 2018 and december 31, 2017, respectively																													14,857,000
property and equipment, net of accumulated depreciation of 19,817 and 18,022 as of march 31, 2018 and december 31, 2017, respectively																														53,927,000
intangible assets, net of accumulated amortization of 4,659 and 4,145 as of march 31, 2018 and december 31, 2017, respectively																														14,473,000
restricted investment																																			10,695,000	10,695,000	10,695,000	10,695,000	10,695,000
property and equipment, net of accumulated depreciation of 18,022 and 30,346 as of december 31, 2017 and 2016, respectively																															43,156,000
intangible assets, net of accumulated amortization of 4,145 and 3,134 as of december 31, 2017 and 2016, respectively																															14,355,000
asset held for sale																																1,501,000	1,529,000	1,529,000
restricted cash and investments																																784,000	784,000	784,000	784,000	784,000	783,000	783,000	783,000	11,478,000	783,000	783,000	782,000
property and equipment, net of accumulated depreciation of 34,677 and 30,346 as of september 30, 2017 and december 31, 2016, respectively																																38,872,000
intangible assets, net of accumulated amortization of 3,762 and 3,134 as of september 30, 2017 and december 31, 2016, respectively																																14,029,000
property and equipment, net of accumulated depreciation of 33,047 and 30,346 as of june 30, 2017 and december 31, 2016, respectively																																	39,393,000
intangible assets, net of accumulated amortization of 2,862 and 3,134 as of june 30, 2017 and december 31, 2016, respectively																																	7,795,000
property and equipment, net of accumulated depreciation of 31,488 and 30,346 as of march 31, 2017 and december 31, 2016, respectively																																		38,412,000
intangible assets, net of accumulated amortization of 2,758 and 3,134 as of march 31, 2017 and december 31, 2016, respectively																																		7,684,000
property and equipment, net of accumulated depreciation of 30,346 and 24,594 as of december 31, 2016 and 2015, respectively																																			37,801,000
intangible assets, net of accumulated amortization of 3,134 and 2,620 as of december 31, 2016 and 2015, respectively																																			8,076,000
current portion of notes payable																																							2,493,000	2,454,000	4,908,000	4,831,000	2,492,000	2,415,000
property and equipment, net of accumulated depreciation of 28,426 and 24,594 as of september 30, 2016 and december 31, 2015, respectively																																				35,620,000
intangible assets, net of accumulated amortization of 3,054 and 2,620 as of september 30, 2016 and december 31, 2015, respectively																																				8,111,000
property and equipment, net of accumulated depreciation of 27,148 and 24,594 as of june 30, 2016 and december 31, 2015, respectively																																					36,158,000
patent costs, net of accumulated amortization of 2,903 and 2,620 as of june 30, 2016 and december 31, 2015, respectively																																					6,991,000
property and equipment, net of accumulated depreciation of 25,826 and 24,594 as of march 31, 2016 and december 31, 2015, respectively																																						36,982,000
patent costs, net of accumulated amortization of 2,774 and 2,620 as of march 31, 2016 and december 31, 2015, respectively																																						6,728,000
property and equipment, net of accumulated depreciation of 24,594 and 19,896 as of december 31, 2015 and 2014, respectively																																							37,344,000
patent costs, net of accumulated amortization of 2,620 and 2,081 as of december 31, 2015 and 2014, respectively																																							6,642,000
notes payable																																											2,262,000	2,262,000
property and equipment, net of accumulated depreciation of 23,368 and 19,896 as of september 30, 2015 and december 31, 2014, respectively																																								37,379,000
patent costs, net of accumulated amortization of 2,486 and 2,081 as of september 30, 2015 and december 31, 2014, respectively																																								6,116,000
property and equipment, net of accumulated depreciation of 22,193 and 19,896 as of june 30, 2015 and december 31, 2014, respectively																																									37,196,000
patent costs, net of accumulated amortization of 2,353 and 2,081 as of june 30, 2015 and december 31, 2014, respectively																																									6,024,000
unrealized loss																																									-19,000
property and equipment, net of accumulated depreciation and amortization of 21,037 and 19,896 as of march 31, 2015 and december 31, 2014, respectively																																										37,759,000
patent costs, net of accumulated amortization of 2,216 and 2,081 as of march 31, 2015 and december 31, 2014, respectively																																										5,842,000
other liabilities																																										1,256,000	1,185,000	1,061,000	1,031,000	1,087,000				15,000	27,000	85,000	107,000	114,000	126,000	105,000	85,000	69,000	35,000	64,000	77,000	98,000		86,000	217,000	324,000	450,160	435,086	143,835	237,585	331,335	1,238,152	1,336,821	1,435,490	346,037	314,167	237,904
deferred rent																																										6,593,000	6,775,000	6,365,000
restricted investments																																												4,000,000	4,000,000	7,250,000	7,250,000	7,250,000	7,250,000	7,250,000
patent costs, net of accumulated amortization of 2,081 and 1,622 as of december 31, 2014 and 2013, respectively																																											5,891,000
warrant liability																																													9,826,000	9,213,000	9,006,000	35,994,000	79,116,000	91,077,000															21,387,000	6,815,000	1,253,580	2,970,857	2,801,882	5,849,341	4,414,657	1,642,246
property and equipment, net of accumulated depreciation and amortization of 18,865 and 17,328 as of september 30, 2014 and december 31, 2013, respectively																																												37,178,000
patent costs, net of accumulated amortization of 1,972 and 1,622 as of september 30, 2014 and december 31, 2013, respectively																																												5,689,000
property and equipment, net of accumulated depreciation and amortization of 17,945 and 17,328 as of june 30, 2014 and december 31, 2013, respectively																																													20,163,000
patent costs, net of accumulated amortization of 1,853 and 1,622 as of june 30, 2014 and december 31, 2013, respectively																																													5,387,000
deferred rent and other long-term liabilities																																													6,459,000	7,118,000	6,835,000
property and equipment, net of accumulated depreciation and amortization																																														20,130,000
patent costs, net of accumulated amortization of 1,740 and 1,622																																														5,217,000
deficit accumulated during the development stage																																														-571,509,000	-543,236,000	-534,416,000	-492,386,000	-473,335,000	-431,251,000	-369,184,000	-319,630,000	-327,668,000	-309,964,000	-308,554,000	-304,534,000	-305,813,000	-307,646,000																													-63,472,543
property and equipment, net of accumulated depreciation and amortization of 17,328 and 16,708																																															15,049,000
patent costs, net of accumulated amortization of 1,622 and 2,626																																															5,042,000
accrued employee compensation																																															5,047,000	2,909,000	1,986,000	1,520,000	2,741,000	2,180,000	1,936,000	1,852,000	2,244,000	2,250,000	2,551,000	2,088,000	2,015,000	2,223,000	1,837,000	495,000		1,098,000	974,000	964,000	1,305,829	1,684,540	1,208,143	1,064,891	1,171,666	1,325,351	1,132,036	1,021,336	680,881	662,500	721,388	886,369		670,222	703,863	793,402	612,370	558,774	581,389	508,632	369,032	400,099
property and equipment, net of accumulated depreciation and amortization of 17,345 and 16,708																																																8,244,000
patent costs, net of accumulated amortization of 1,538 and 2,626																																																5,231,000
other long-term liabilities																																																4,795,000	757,000	755,000	760,000	758,000	757,000	967,000	993,000	1,022,000	1,046,000	1,070,000	1,094,000	1,069,000	1,075,000	1,108,000		610,000	579,000	530,000	515,621	495,002	474,385	453,767	433,149
property and equipment, net of accumulated depreciation and amortization of 17,173 and 16,708																																																	3,359,000
patent costs, net of accumulated amortization of 1,439 and 2,626																																																	5,186,000
long-term debt, current portion																																																	90,000	90,000	89,000	88,000	87,000	86,000	85,000	84,000	83,000	82,000	81,000	80,000	79,000	78,000		76,000	76,000	75,000	73,877	73,672	72,804	25,994	71,099	70,261	69,434
long-term debt, non-current portion																																																	1,622,000		1,668,000	1,690,000	1,713,000	1,735,000	1,757,000	1,778,000	1,800,000	1,821,000	1,842,000	1,863,000	1,883,000	1,903,000		1,950,000	1,962,000	1,981,000	2,000,789	2,015,124	2,033,871	2,098,349	2,070,704	2,088,797	2,106,675
property and equipment, net of accumulated depreciation and amortization of 17,024 and 16,708																																																		3,088,000
patent costs, net of accumulated amortization of 1,534 and 2,626																																																		4,883,000
liabilities and shareholders’ equity
shareholders’ equity:
total shareholders’ equity																																																		87,281,000	123,679,000	-4,566,000	22,500,000	14,022,000		31,752,000	35,149,000	920,000	-2,817,000	4,163,000	8,441,000			19,504,000	3,788,000	22,890,000	15,731,842	16,338,762	21,243,010	20,786,138	26,381,748	15,225,708	24,214,945	30,960,292	44,359,212	50,119,195	55,909,244	53,660,009	36,993,888	38,616,289	43,420,299	26,269,033	31,023,757	35,975,169
total liabilities and shareholders’ equity																																																		193,340,000	204,993,000	53,082,000	42,101,000	46,647,000		61,083,000	74,933,000	47,031,000	45,976,000	50,860,000	48,667,000			65,123,000	32,617,000	37,017,000	25,535,828	29,514,946	32,578,172	35,479,866	38,637,930	26,864,835	31,208,514	35,307,047	46,542,091	52,384,016	58,119,048	56,407,982	39,516,477	40,542,949	45,698,213	28,518,631	32,373,194	38,142,082
property and equipment, net of accumulated depreciation and amortization of 16,708 and 15,765																																																			3,397,000
patent costs, net of accumulated amortization of 2,626 and 2,199																																																			4,913,000
warrant valuation																																																			65,193,000	45,209,000	2,884,000	16,372,000	5,446,000	12,889,000	19,940,000	31,193,000	39,111,000	33,118,000	29,540,000	20,500,000		35,400,000
property and equipment, net of accumulated depreciation and amortization of 16,444 and 15,765																																																				3,661,000
patent costs, net of accumulated amortization of 2,521 and 2,199																																																				4,837,000
property and equipment, net of accumulated depreciation and amortization of 16,208 and 15,765																																																					3,898,000
patent costs, net of accumulated amortization of 2,413 and 2,199																																																					4,740,000
property and equipment, net of accumulated depreciation and amortization of 15,982 and 15,765																																																						4,105,000
patent costs, net of accumulated amortization of 2,298 and 2,199																																																						4,704,000
preferred stock, .0001 par value, 20,000,000 shares authorized; none issued and outstanding																																																						0
property held for sale																																																								1,856,000	1,965,000	1,965,000	1,965,000	1,979,000	2,372,000	2,372,000
property and equipment, net of accumulated depreciation and amortization of 15,765 and 14,963																																																							4,265,000
patent costs, net of accumulated amortization of 2,199 and 1,742																																																							4,764,000
liabilities and shareholders' equity
shareholders' equity
total shareholders' equity																																																							31,017,000							23,473,000																							23,481,623	30,534,047	37,758,345	28,838,327
total liabilities and shareholders' equity																																																							54,368,000							52,825,000																							28,603,757	33,815,113	39,372,503	30,456,128
property and equipment, net of accumulated depreciation and amortization of 15,542 and 14,963																																																								2,445,000
patent costs, net of accumulated amortization of 1,901 and 1,742																																																								4,698,000
shareholders’ equity
property and equipment, net of accumulated depreciation and amortization of 15,338 and 14,963																																																									2,363,000
patent costs, net of accumulated amortization of 1,845 and 1,742																																																									4,459,000
property and equipment, net of accumulated depreciation and amortization of 15,150 and 14,963																																																										2,111,000
patent costs, net of accumulated amortization of 1,790 and 1,742																																																										4,074,000
property and equipment, net of accumulated depreciation and amortization of 14,963 and 14,026																																																											2,070,000
patent costs, net of accumulated amortization of 1,742 and 1,762																																																											3,980,000
property and equipment, net of accumulated depreciation and amortization of 14,678 and 14,026																																																												2,155,000
patent costs, net of accumulated amortization of 1,870 and 1,762																																																												4,301,000
property and equipment, net of accumulated depreciation and amortization of 14,393 and 14,026																																																													2,184,000
patent costs, net of accumulated amortization of 1,829 and 1,762																																																													4,068,000
short-term securities —available-for-sale																																																														172,000
property and equipment, net of accumulated depreciation and amortization of 14,138 and 14,026																																																														2,361,000
patent costs, net of accumulated amortization of 1,787 and 1,762																																																														3,832,000
shareholders' equity:
operating leases																																																															2,387,000
royalty payments																																																															250,000
report of kpmg llp, independent registered public accounting firm
report of arthur andersen, independent auditors
balance sheets
statements of operations
statements of shareholders’ equity and comprehensive income
statements of cash flows
notes to financial statements
short-term securities—available-for-sale																																																																169,000	168,000	285,000	282,062	279,528	276,618	274,209	271,851	10,188,487	10,056,789	12,081,196	12,846,772	12,709,104		12,453,348	3,400,631	4,840,163	2,834,650	2,860,487		18,129,230	8,908,682		6,596,477	4,618,206
property and equipment, net of accumulated depreciation and amortization of 13,735 and 12,919																																																																2,102,000
patent costs, net of accumulated amortization of 1,959 and 1,927																																																																3,580,000		3,269,000
assets held for sale																																																																2,373,000
property and equipment, net of accumulated depreciation and amortization of 13,492 and 12,919																																																																	4,758,000
patent costs, net of accumulated amortization of 1,891 and 1,927																																																																	3,452,000
accumulated other comprehensive income deficit accumulated during the development stage
property and equipment, net of accumulated depreciation and amortization of 13,207 and 12,919																																																																		4,934,000
property and equipment, net of accumulated depreciation and amortization of 12,919,371 and 11,816,549																																																																			5,188,984
patent costs, net of accumulated amortization of 1,926,941 and 1,725,074																																																																			3,267,778
property and equipment, net of accumulated depreciation and amortization of 12,630,586 and 11,816,549																																																																				6,277,736
patent costs, net of accumulated amortization of 1,858,214 and 1,725,074																																																																				3,542,520
property and equipment, net of accumulated depreciation and amortization of 12,332,638 and 11,816,549																																																																					6,474,073
patent costs, net of accumulated amortization of 1,813,214 and 1,725,074																																																																					3,522,911
property and equipment, net of accumulated depreciation and amortization of 12,111,844 and 11,816,549																																																																						6,677,465
patent costs, net of accumulated amortization of 1,766,674 and 1,725,074																																																																						3,404,340
property and equipment, net of accumulated depreciation and amortization of 11,816,549 and 10,174,712																																																																							6,825,145
patent costs, net of accumulated amortization of 1,725,074 and 1,496,699																																																																							3,066,625
property and equipment, net of accumulated depreciation and amortization of 11,472,216 and 10,174,712																																																																								7,099,321
patent costs, net of accumulated amortization of 1,674,130 and 1,496,699																																																																								2,976,692
property and equipment, net of accumulated depreciation and amortization of 11,034,187 and 10,174,712																																																																									7,189,503
patent costs, net of accumulated amortization of 1,580,130 and 1,496,699																																																																									2,769,042
property and equipment, net of accumulated depreciation and amortization of 10,603,407 and 10,174,712																																																																										4,103,482
patent costs, net of accumulated amortization of 1,533,630 and 1,496,699																																																																										2,611,476
property and equipment, net of accumulated depreciation and amortization of 9,727,912 and 8,396,923																																																																											4,745,658
patent costs, net of accumulated amortization of 1,435,381 and 1,270,881																																																																											2,472,389
property and equipment, net of accumulated depreciation and amortization of 9,269,104 and 8,396,923																																																																												4,935,608
patent costs, net of accumulated amortization of 1,373,381 and 1,270,881																																																																												2,312,323
short-term securities–available-for-sale																																																																													12,579,208									14,527,670
property and equipment, net of accumulated depreciation and amortization of 8,826,044 and 8,396,923																																																																													5,153,921
patent costs, net of accumulated amortization of 1,320,381 and 1,270,881																																																																													2,163,209
property and equipment, net of accumulated depreciation and amortization of 8,396,923 and 6,729,046																																																																														5,599,269
patent costs, net of accumulated amortization of 1,270,881 and 1,061,788																																																																														2,117,710
property and equipment, net of accumulated depreciation and amortization of 8,029,405 and 6,729,046																																																																															5,887,787
patent costs, net of accumulated amortization of 1,216,288 and 1,061,788																																																																															2,091,142
accrued employee compensation and deferred revenue																																																																															881,328
property and equipment, net of accumulated depreciation and amortization of 7,595,485 and 6,729,046																																																																																6,007,775
patent costs, net of accumulated amortization of 1,161,788 and 1,061,788																																																																																2,066,631
property and equipment, net of accumulated depreciation and amortization of 7,163,351 and 6,729,046																																																																																	6,143,778
patent costs, net of accumulated amortization of 1,109,788 and 1,061,788																																																																																	2,042,217
property and equipment, net of accumulated depreciation and amortization of 6,729,046 and 5,198,912																																																																																		6,313,644
patent costs, net of accumulated amortization of 1,061,788 and 877,038																																																																																		1,968,987
short-term securities-available-for-sale																																																																																			10,762,976
property and equipment, net of accumulated depreciation and amortization of 6,412,930 and 5,198,912																																																																																			6,588,211
patent costs, net of accumulated amortization of 1,010,038 and 877,038																																																																																			1,946,660
property and equipment, net of accumulated depreciation and amortization of 5,987,785 and 5,198,912																																																																																				6,565,275
patent costs, net of accumulated amortization of 964,038 and 877,038																																																																																				1,893,643
related party receivables																																																																																					513,250	1,715,032
property and equipment, net of accumulated depreciation and amortization of 4,007,186 and 2,941,458																																																																																					6,584,290
patent costs, net of accumulated amortization of 727,901 and 694,193																																																																																					1,587,632
property and equipment, net of accumulated depreciation and amortization of 2,941,458 and 2,658,549																																																																																						4,897,788
patent costs, net of accumulated amortization of 694,193 and 541,185																																																																																						1,376,402
preferred stock, .0001 par value, 2,000,000 shares authorized; none issued and outstanding
property and equipment, net of accumulated depreciation and amortization of 2,778,776 and 2,658,549																																																																																							2,423,962
patent costs, net of accumulated amortization of 606,185 and 541,185																																																																																							1,058,738
property and equipment, net of accumulated depreciation and amortization of 2,720,317 and 2,658,549																																																																																								1,993,383
patent costs, net of accumulated amortization of 571,185 and 541,185																																																																																								954,764

We provide you with 20 years of balance sheets for Sarepta Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sarepta Therapeutics. Explore the full financial landscape of Sarepta Therapeutics stock with our expertly curated balance sheets.

The information provided in this report about Sarepta Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.